|
[1]
|
Strauss, R.M. and Boyer, T.D. (1997) Hepatic hydrothorax. Semin Liver Disease, 17, 227-232.
doi:10.1055/s-2007-1007200
|
|
[2]
|
Albals, W.M., Salem, A.J., Solomon, D.A., et al. (1991) Hepatic hydrothorax: Cause and management. Archives of Internal Medicine, 151, 2383-2388.
doi:10.1001/archinte.1991.00400120029005
|
|
[3]
|
Kakizaki, S., Katakai, K. and Yoshinaga, T. (1998) Hepatic hydrothorax in the absence of ascites. Liver, 18, 216220. doi:10.1111/j.1600-0676.1998.tb00154.x
|
|
[4]
|
Alberts, W.M., Salem, A.J., Solomon, D.A., et al. (1991) Hepatic hydrothorax. Cause and management. Archives of Internal Medicine, 151, 2383-2388.
doi:10.1001/archinte.1991.00400120029005
|
|
[5]
|
Ackerman, Z. and Reynolds, T.B. (1997) Evaluation of pleural fluid in patients with cirrhosis. Journal of Clinical Gastroenterology, 25, 619-622.
doi:10.1097/00004836-199712000-00014
|
|
[6]
|
Romero, S., Martín, C., Hernandez, L., et al. (1998) Chylothorax in cirrhosis of the liver—Analysis of its frequency and clinical characteristics. Chest, 114, 154-159.
doi:10.1378/chest.114.1.154
|
|
[7]
|
Xiol, X., Castellote, J., Cortes-Beut, R., et al. (2001) Usefulness and complications of thoracocentesis in cirrhotic patients. American Journal of Medicine, 111, 67-69.
doi:10.1016/S0002-9343(01)00744-6
|
|
[8]
|
Milanez de Campos, J.R., Filho, E.A., Webre, E.C., et al. (2000) Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest, 118, 13-17.
doi:10.1378/chest.118.1.13
|
|
[9]
|
Zaloznik, A.J., Oswald, S.G. and Langin, M. (1983) Intrapleural tetracycline in malignant pleural effusions. Cancer, 51, 752-755.
doi:10.1002/1097-0142(19830215)51:4<752::AID-CNCR2820510434>3.0.CO;2-7
|
|
[10]
|
Borchardt, J., Smirnov, A., Metchnik, L., et al. (2003) Treating hepatic hydrothorax. British Medical Journal, 326, 751-752. doi:10.1136/bmj.326.7392.751
|
|
[11]
|
Liu, L., Haddadin, H.A., Bodian, C.A., et al. (2004) Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest, 126, 142-148.
doi:10.1378/chest.126.1.142
|
|
[12]
|
Ferrante, D., Arguedas, M.R., Cerfolio, R.J., et al. (2002) Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. American Journal of Gastroenterology, 97, 31723175. doi:10.1111/j.1572-0241.2002.07126.x
|
|
[13]
|
Kotran, R., Kumar, V. and Collins, T. (1999) Robbins pathologic basis of disease. 6th Edition, WB Saunders, Philadelphia, 89-134.
|
|
[14]
|
Walker-Renard, P.B., Vaughan, L.M. and Sahn, S.A. (1994) Chemical pleurodesis for malignant pleural effusions. Annals of Internal Medicine, 120, 56-64.
doi:10.7326/0003-4819-120-1-199401010-00010
|
|
[15]
|
Merriam, M.A., Cronan, J.J., Dorfman, G.S., et al. (1988) Radiographically guided percutaneous catheter drainage of pleural fluid collections. American Journal of Roentgenology, 151, 1113-1116. doi:10.2214/ajr.151.6.1113
|
|
[16]
|
Cardenas, A., Kelleher, T. and Chopra, S. (2004) Review article: Hepatic hydrothorax. Aliment Pharmacological Therapy, 20, 271-279.
doi:10.1111/j.1365-2036.2004.02081.x
|
|
[17]
|
Runyon, B.A., Greenblatt, M. and Ring, M.H.C. (1986) Hepatic hydrothorax is a relative contraindication to chest tube insertion. American Journal of Gastroenterology, 81, 566-567.
|
|
[18]
|
Ruckdeschel, J.C., Moores, D., Lee, J.Y., et al. (1991) Intrapleural therapy for malignant pleural effusions: A randomized comparison of bleomycin and tetracycline. Chest, 100, 1528-1535. doi:10.1378/chest.100.6.1528
|
|
[19]
|
Umit, A., Servet, O., Levent, C., et al. (2009) Bedside talc pleurodesis for malignant pleural effusion: Factors affecting success. Annals of Surgical Oncology, 16, 745750. doi:10.1245/s10434-008-0263-x
|
|
[20]
|
Morales-Gomez, J., Tellez-Becerra, J.L., Martinez-Ormeno, J.E., et al. (1993) Pleurodesis with iodopovidone in malignant pleural effusions. Revistadel Instituto Nacionalde Enfermedades Respiratorias Mexico, 6, 71-74.
|
|
[21]
|
Kelly-Garcia, J., Roman-Berumen, J.F. and Ibarra-Perez, C. (1997) Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Archives of Medical Research, 28, 583-585.
|
|
[22]
|
Barbetakis, N., et al. (2004) Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer. BMC Palliative Care, 3, 4.
doi:10.1186/1472-684X-3-4
|
|
[23]
|
Shaw, P. and Agawal, R. (2004) Pleurodesis for malignnant pleural effusion. (Cochrane Review) The Cochrane Library, 4.
|
|
[24]
|
Steven, A.S. (2001) Malignant pleural effusion. Seminars in Respiratory and Critical Care Medicine, 22, 607-615.
doi:10.1055/s-2001-18796
|
|
[25]
|
Antunes, G., et al. (2003) BTS guidelines for the management of malignant pleural effusions. Thorax, 58, 11291138. doi:10.1136/thorax.58.suppl_2.ii29
|
|
[26]
|
Maskell, N.A., Lee, Y.C., Gleeson, F.V., et al. (2004) Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. American Journal of Respiratory and Critical Care Medicine, 170, 377-382. doi:10.1164/rccm.200311-1579OC
|
|
[27]
|
Olivares-Torres, C.A., Eaniado-Eaborin, R., Chavez-Garcia, C., et al. (2002) Lodopovidone pleurodesis for recurrent pleural effusions. Chest, 122, 581-583.
doi:10.1378/chest.122.2.581
|
|
[28]
|
Brant, A. and Eaton, T. (2001) Serious complications with talc slurry pleurodesis. Respirology, 6, 181-185.
doi:10.1046/j.1440-1843.2001.00327.x
|
|
[29]
|
Gines, P., Arroyo, V., Rodes, J. and Schrier, R. (2005) Ascites and renal dysfunction in liver disease: Pathogenesis diagnosis and treatment. 2nd Edition, Blackwell Publishing Ltd. doi:10.1002/9780470987476
|